Cargando…
Surface Stabilization and Dissolution Rate Improvement of Amorphous Compacts with Thin Polymer Coatings: Can We Have It All?
[Image: see text] The distinction between surface and bulk crystallization of amorphous pharmaceuticals, as well as the importance of surface crystallization for pharmaceutical performance, is becoming increasingly evident. An emerging strategy in stabilizing the amorphous drug form is to utilize th...
Autores principales: | Novakovic, Dunja, Peltonen, Leena, Isomäki, Antti, Fraser-Miller, Sara J., Nielsen, Line Hagner, Laaksonen, Timo, Strachan, Clare J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145361/ https://www.ncbi.nlm.nih.gov/pubmed/32027513 http://dx.doi.org/10.1021/acs.molpharmaceut.9b01263 |
Ejemplares similares
-
Understanding Dissolution and Crystallization with
Imaging: A Surface Point of View
por: Novakovic, Dunja, et al.
Publicado: (2018) -
Image-based dissolution analysis for tracking the surface stability of amorphous powders
por: Štukelj, Jernej, et al.
Publicado: (2020) -
Crystallization Kinetics of an Amorphous Pharmaceutical
Compound Using Fluorescence-Lifetime-Imaging Microscopy
por: Rautaniemi, Kaisa, et al.
Publicado: (2018) -
Polymer Nanocoating of Amorphous Drugs for Improving
Stability, Dissolution, Powder Flow, and Tabletability: The Case of
Chitosan-Coated Indomethacin
por: Li, Yuhui, et al.
Publicado: (2019) -
Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery
por: Peltonen, Leena, et al.
Publicado: (2015)